Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

VTYX vs VALN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VTYX Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

VTYX Overall Winner 6-Pillar Tally: VTYX 3 – 3 VALN Matrix Metrics: VTYX 7 – 3 VALN

As of Nov 16, 2026, Ventyx Biosciences, Inc. (VTYX) is the stronger overall head-to-head candidate over Valneva SE (VALN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). VTYX carries a Unified Composite Score of 50.4/100 (HOLD) at $14.00 (N/M Forward P/E, 0.0% operating margin), whereas VALN carries 50.9/100 (HOLD) at $5.59 (4.8x Forward P/E, -80.4% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VTYX vs VALN
VTYX NASDAQ Head-to-Head Winner
Ventyx Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$14.00
+0.14% 1D
Market Cap $1.0B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.07β · 2% Vol
Unified Composite Score
50.4 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (19.0% over 20 days), RSI 71
RSI-14: 70.7 · SMA20: $13.96 · SMA50: $12.72
VALN NASDAQ
Valneva SE American Depositary Shares
Biological Products, (No Diagnostic Substances)
$5.59
-1.24% 1D
Market Cap $547.9M
TTM Revenue $143M
Forward P/E 4.8x
Beta / 30D Vol 0.40β · 43% Vol
Unified Composite Score
50.9 / 100 HOLD
Tech 42.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 52.7 · SMA20: $5.60 · SMA50: $5.95

6-Pillar Scorecard Institutional Category Breakdown (VTYX 3 – 3 VALN)

Columns: Metric · VTYX · VALN
1. Valuation Multiples VALN
Forward P/E N/M 4.8x
Trailing P/E N/M 8.4x
PEG Ratio N/M N/M
EV / Revenue N/M 3.8x
2. Growth & Scale VTYX
Revenue Growth (YoY) +0.0% -27.7%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $143M
Market Cap $1.0B $547.9M
3. Profitability & Quality VTYX
Gross Margin N/A -41.7%
Operating Margin 0.0% -80.4%
Net Profit Margin 0.0% -110.3%
Return on Equity (ROE) -45.4% -117.9%
4. Balance Sheet & Cash Flow VALN
Cash Generation (TTM) N/A -$99M EBITDA
Cash Flow Margin N/A -69.1% EBITDA Mgn
Net Cash / Leverage $2.68 Book/Sh · -45.4% ROE $0.96 Book/Sh · -117.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning VTYX
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 0.5% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat VALN
OpEx & R&D Intensity N/A 38.7% of Rev ($55M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VTYX (7) vs VALN (3)
Institutional Metric VTYX VALN Criterion Row Edge
Market Capitalization
Scale
$1.0B $547.9M Larger Scale VTYX
Trailing P/E Ratio
Valuation
N/M 8.4x Lower Multiple VALN
Forward P/E Ratio
Valuation
N/M 4.8x Lower Multiple VALN
Revenue Growth (YoY)
Growth
+0.0% -27.7% Higher Growth VTYX
Operating Margin (TTM)
Profitability
0.0% -80.4% Higher Margin VTYX
Net Profit Margin
Profitability
0.0% -110.3% Higher Margin VTYX
Return on Equity (ROE)
Capital Efficiency
-45.4% -117.9% Higher ROE VTYX
52-Week Range Position
Momentum
55% ($1–$25) 11% ($5–$12) Stronger Trend VTYX
Beta / 30D Volatility
Risk Regime
2.07β · 2% Vol 0.40β · 43% Vol Lower Realized Risk VTYX
Unified Institutional Score
Composite Signal
50.4 / 100 (HOLD) 50.9 / 100 (HOLD) Higher Composite VALN
Trailing 12M Revenue (USD)
Operating Scale
N/A $143M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A -41.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 3.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($2.68 Book/Sh · -45.4% ROE) -$99M EBITDA ($0.96 Book/Sh · -117.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VALN +10.93 pp
VTYX: +0.36% · VALN: +11.29%
3M Horizon VTYX +30.43 pp
VTYX: +40.0% · VALN: +9.57%
6M Horizon VTYX +35.55 pp
VTYX: +46.6% · VALN: +11.05%
1Y Horizon VTYX +35.55 pp
VTYX: +46.6% · VALN: +11.05%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VTYX vs VALN. Trailing 12-month operating profitability (VTYX 0.0% vs VALN -80.4%) and valuation multiples (VTYX N/M vs VALN 4.8x Forward P/E) are benchmarked directly in Pillar 4 below.

VTYX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-45.4% · N/M
VALN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$143M
Gross Margin-41.7%
Op. Margin-80.4%
ROE / Fwd P/E-117.9% · 4.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VTYX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 0.5%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VTYX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VALN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VALN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VTYX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.0B market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
VALN Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $547.9M market capitalization and -80.4% operating margin.
OpEx & R&D Reinvestment 38.7% of Rev ($55M)
90D Engineering Disclosures 0 Published

Investor FAQ VTYX vs VALN Key Questions & Quantitative Answers

As of Nov 16, 2026, Ventyx Biosciences, Inc. (VTYX) is the stronger overall head-to-head candidate over Valneva SE (VALN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). VTYX carries a Unified Composite Score of 50.4/100 (HOLD) at $14.00 (N/M Forward P/E, 0.0% operating margin), whereas VALN carries 50.9/100 (HOLD) at $5.59 (4.8x Forward P/E, -80.4% operating margin). Technically, VTYX sits in a Markup phase (RSI 70.7, UNCLASSIFIED options structure) and VALN sits in a Neutral phase (RSI 52.7, UNCLASSIFIED options structure).

VTYX leads the Growth & Scale pillar: VTYX posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with VALN at -27.7% YoY revenue growth and +0.0% YoY earnings growth on $143M TTM revenue (-41.7% gross margin, -80.4% operating margin). On trailing 12-month operating scale, VTYX generates N/A in USD-normalized revenue versus $143M for VALN. In operating R&D and SG&A reinvestment, VTYX deploys N/A (0 90-day corporate R&D disclosures) versus 38.7% of Rev ($55M) (0 disclosures) for VALN.

VALN screens cheaper on headline valuation multiples. VTYX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas VALN trades at 4.8x Forward P/E, 8.4x Trailing P/E, N/M PEG, and 3.8x EV/Revenue (-69.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VTYX (-45.4% ROE) versus VALN (-117.9% ROE) capital efficiency.

In options market volatility and institutional positioning, VTYX carries 0.5% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.07β · 2% Vol realized risk). By comparison, VALN carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.40β · 43% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.